Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FMVWY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,881
Award facts
- Contract value 100% obligated
- $2,881.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes valued at $2,881.36, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XOLAIR (omalizumab) is a monoclonal antibody used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria, making this acquisition part of the Defense Health Agency's pharmaceutical supply chain supporting military healthcare needs.
This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains significant federal contracting relationships and demonstrates capability to fulfill specialized medical procurement requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DB25FMVWY?
SPE2DB25FMVWY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FMVWY worth?
The government has obligated $2,881 on SPE2DB25FMVWY.
Is contract SPE2DB25FMVWY an order under another contract?
Yes. SPE2DB25FMVWY is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMVWY competed?
The extent of competition for SPE2DB25FMVWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award